CCNE1 and neoplasm: Amplification of CCNE1 has been identified in diverse tumor types including approximately 12% of esophagogastric cancer (EGC) and 20% of high-grade serous ovarian cancers from The Cancer Genome Atlas (TCGA) analysis (10).